Waldenström Macroglobulinemia: Mechanisms of Disease Progression and Current Therapies

Waldenström macroglobulinemia is an indolent, B-cell lymphoma without a known cure. The bone marrow microenvironment and cytokines both play key roles in Waldenström macroglobulinemia (WM) tumor progression. Only one FDA-approved drug exists for the treatment of WM, Ibrutinib, but treatment plans in...

Descripción completa

Detalles Bibliográficos
Autores principales: Boutilier, Ava J., Huang, Lina, Elsawa, Sherine F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569492/
https://www.ncbi.nlm.nih.gov/pubmed/36232447
http://dx.doi.org/10.3390/ijms231911145

Ejemplares similares

Ejemplares similares